2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….
Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients